{"id":"W2763770778","doi":"10.1093/annonc/mdx368","title":"Pembrolizumab for patients with PD-L1–positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Neuroendocrine tumors; Internal medicine; Carcinoid syndrome; Clinical endpoint; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Carcinoid tumors; Phases of clinical research; Toxicity; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001404929,0.0007073143,0.001169257,0.0002165787,0.0002833858,0.0008828359,0.0004362115,0.0006303904,0.00137668],"category_scores_gemma":[0.00133527,0.0003456329,0.001572554,0.0004517858,0.0003365034,0.00101805,0.0003849532,0.001583475,0.0004189217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007226511,"about_ca_system_score_gemma":0.000623991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001094536,"about_ca_topic_score_gemma":0.002761195,"domain_scores_codex":[0.9995053,0.0002124781,0.0000372479,0.0001017221,0.00006644064,0.0000767472],"domain_scores_gemma":[0.999337,0.0001841328,0.0001939537,0.00006551211,0.00005907496,0.0001603236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5632563,0.008393793,0.2220031,0.001856761,0.01887849,0.0005449143,0.0003173118,0.001965448,0.01751745,0.0003695395,0.009763942,0.1551331],"study_design_scores_gemma":[0.2727019,0.08191764,0.5983731,0.000382796,0.022341,0.0009482943,0.0004536604,0.001715703,0.003207203,0.0006963802,0.01715491,0.0001074457],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906399,0.00511435,0.0001618963,0.0005136193,0.00008377533,0.0001990864,0.001567599,0.00001276634,0.001706998],"genre_scores_gemma":[0.9925129,0.002582829,0.0002774512,0.0007384604,0.0001285342,0.0002022912,0.002797651,0.00000943339,0.0007505127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001404929,"threshold_uncertainty_score":0.007430077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07114646937290031,"score_gpt":0.4065153330562797,"score_spread":0.3353688636833794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}